We are live on ! Find out more
TRDA icon

Entrada Therapeutics

120 hedge funds and large institutions have $343M invested in Entrada Therapeutics in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

47% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 32

28% more capital invested

Capital invested by funds: $269M → $343M (+$74.6M)

5% more funds holding

Funds holding: 114120 (+6)

2.62% more ownership

Funds ownership: 68.47%71.09% (+2.6%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
1.48%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
20
Increased
47
Reduced
32
Closed
13
Calls
$292K
Puts
Net Calls
+$292K
Net Calls Change
+$176K
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
126
Walleye Capital
New York
-$139K -13,534 Closed
MF
127
Magnetar Financial
Illinois
-$137K -13,373 Closed
IIM
128
INTECH Investment Management
Florida
-$123K -11,929 Closed
AC
129
AXQ Capital
New Jersey
-$109K -10,650 Closed
Royal Bank of Canada
130
Royal Bank of Canada
Ontario, Canada
-$11K -962 -97%
AB
131
Amalgamated Bank
New York
-$9K -894 Closed
Daiwa Securities Group
132
Daiwa Securities Group
Japan
-$2K -150 Closed
C
133
Covestor
United Kingdom
-$1K -99 Closed